Precision Microbiota
Detection
Uncover diversity, abundance and dysbiosis architecture—revealing
breaches in your biological equilibrium.
Among the vast sea of humanity, children with autism shine like distant stars—isolated within their own worlds by invisible barriers. Social disconnect, repetitive behaviors.and unspoken gut distress torment them relentlessly. Countless families navigate this journey anxious yet directionless—until ChoeStar emerged from TreatGut Pharmaceutical Group, etched with love and hope.
Twelve years ago, Dr. Xiao witnessed a breakthrough miracle while treating five-year-old autistic twins shackled by autism and afflicted by severe gastrointestinal disorders. Post comprehensive nutrition intervention and fecal microbiota transplantation (FMT), not only did their gut ailments improve, but core autism symptoms demonstrated progressive alleviation.
This profound experience, filled with heartfelt warmth and inspiration, ignited Dr. Xiao's mission and commitment. In 2024, he launched the StarLeader Initiative—a nonprofit project pioneering gut microbiota sequencing for 100,000 Chinese autistic children, forging scientific pathways to recovery.
To actualize this vision, ChoeStar (肠益星, “Gut-Benefiting Stars”) was born—tailoring solutions for neurodiverse needs, guarding these “children of the stars” through gut health. Neurodevelopment Microbiome Profiling: Child-Specific Precision Mapping. Delivers deep risk analysis and precision clinical guidance through patented enterotype-neurodevelopment correlation algorithms. “Jin Zhi Yi Xing Wan” effectively addresses treatment non-compliance in children and parental resistance to conventional therapies through its innovative formulation. ChoeStar Post-Procedure Wellness System and Five-Dimensional Nutritional Supplements Providing comprehensive support for children's recovery and development.
Guided by scientific rigor and fueled by compassionate dedication, ChoeStar steadfastly illuminates the gut-brain circuitry—bringing light to every neurodiverse child and warmth to every family navigating autism.
Product system
PRODUCT ECOSYSTEM
Tri-System Framework · The Essential Path to Vitality
Advancing Microecological Frontiers, High-Dimensional Microbiota Database, Human-Derived Strain Bank Platform, Tackling Colonization Challenges, Metabolic Factor Research, Microbial Atlas Analytics Framework. ChoeStar leverages cutting-edge strain platforms and advanced detection technologies to establish its “Precision Microecology Vitality Restoration System.”
Precision Microbiota Detection
Uncover diversity, abundance and dysbiosis architecture—revealing breaches in your biological equilibrium.
Precision Microbiota Transplantation
Through precision-guided microbial remodeling,we restore structural stability to the gut ecosystem.
Precision-Tailored Probiotic Complex
Harnessing microbial synergy and targeted nutrients to build a sustainable cultivation ecosystem.
Intestinal Microbiota Gene Testing
Gut insights reveal the star; ChoeStar ignites childhood.
n the journey of growth, gut harmony nurtures neurological serenity. A child's gut microbiota is the hidden developmental constellation linking body and mind. ChoeStar Microbiota Profiling transcends routine screening—it is a precision exploration into the intrinsic rhythms and developmental roots of neurodiverse children.
We illuminate microbial equilibrium and dysregulation through sequencing as our lens; along the gut-brain axis, we decipher the code linking developmental risks and behavioral patterns.
Here begins the transformation: Recovery evolves from distant hope to an evidence-based, precision-guided pathway of promise.
Precision Profiling: Unlocking Autism's Health Code
Leveraging cutting-edge multi-omics technologies and advanced data analytics, we conduct comprehensive assessments for children with Autism Spectrum Disorder(ASD). Focusing on the gut microbiome as the human “second genome”, we employ full-length 16S sequencing to delineate microbial structure, functionality, and diversity—identifying signature microbiota with potential ASD correlations. Concurrently, we perform integrated assessment of gastrointestinal symptoms —utilizing high-resolution motility monitoring and digestive enzyme activity assays —to precisely quantify digestive capacity and distinguish functional vs. organic disorders.Integrating multidimensional behavioral scales, polysomnography (PSG), and inflammatory biomarker profiling , we holistically analyze sleep architecture, emotional states, and inflammatory drivers —enabling precise diagnostic stratification.Through advanced machine learning models and big data analytics, we deliver precise health forecasting for children with ASD —generating evidence-based clinical support for personalized intervention protocols.
Transplantation
Settling the Gut with Microbes, Kindling the Inner Light of Star Children.
If profiling is revealing order, transplantation is restoring order.This transcends mere microbial transfer—it is precision microecological remodeling.Premium donor microbiota serves as the foundation, while precision matching establishes the clinical standard.We transplant vibrant “fertile microbial terrain” to reboot a balanced，harmonious and unobstructed gut-brain symbiosis within neurodiverse children—where intestinal vitality and neurological well-being flourish in concert.This defines the core and unique medical practice of ChoeStar, and is also a warm practice of guarding neurology through enteric care, illuminating the growth journey of these star children.
Innovative Transplantation — “Jin Zhi Yi Xing Wan” Supports Recovery in Neurodiverse Children
“Jin Zhi Yi Xing Wan”: Our Meticulously Developed, Revolutionary Microbiota Transplantation Product. It fuses cutting-edge biotechnology with traditional medical wisdom, harnessing premium microbiota from rigorously screened donors. Through a multi-step protocol—selection, cultivation, purification, and lyophilization—we ensure optimal viability and validated therapeutic efficacy. For comorbidities in children with special needs, particularly those represented by autism, Jin Zhi Yi Xing Wan remodels gut microecological balance… By improving gut barrier function, reducing intestinal inflammation, and promoting the synthesis and metabolism of neurotransmitters, it breaks through the bottlenecks of conventional rehabilitation, significantly enhances therapeutic efficacy, and brings new hope for the healthy growth of children with special needs.
Health & Wellness
ChoeStar Probiotic Solid Beverage (Live Probiotics)
Effectively improves children's emotional well-being and sleep quality, promotes food digestion and nutrient absorption, and provides comprehensive support for healthy growth..
Strain Function Matrix
Lacticaseibacillus paracasei Lpc-37:
Regulates serotonin synthesis to improve emotional stability.
Bifidobacterium longum subsp. infantis Bl-26:
Enhances intestinal barrier function and reduces endotoxin entry into bloodstream.
Bifidobacterium animalis subsp. lactis 04:
Promotes tryptophan metabolism for optimized sleep architecture.
Lacticaseibacillus rhamnosus HN001/TG021:
Inhibits pathogenic bacterial adhesion and decreases inflammatory cytokine release.
Limosilactobacillus fermentum TG017:
Modulates Th1/Th2 balance to alleviate allergic reactions.
Technical Advantages
≥200 billion CFU per sachet.Droplet microfluidic
encapsulation technology ensures 94.8% viability retention in the gastric acid environment, providing robust support for viable strains to reach the intestines.
Nutritional Supplement
consider gastrointestinal symptoms, digestive capacity, sleep quality, emotional states, and inflammation levels to scientifically combine multiple nutrients into a blend. This provides comprehensive, balanced nutritional support for autistic children, supporting their healthy growth and development.
Children on the autism spectrum often face comorbidities: diarrhea, constipation, selective eating, weakened immunity, and sleep and emotional instability. These seemingly disparate challenges share a common root—gut microbiota dysbiosis.
Guided by founder Dr.Xiao's original vision, TreatGut Pharmaceutical Group launched “the StarLeader Initiative” , focusing on gut microecology as the core to root-cause alleviate children's physical comorbidities, break rehabilitation bottlenecks, and effectively improve outcomes.
We hold steadfast: Gut serenity enables neurological calm; intestinal health empowers steady progress. With professional expertise, we safeguard gut health.With the light of science, we accompany the growth of children with autism-enabling every every child with autism to break through barriers and integrate into society.
Where no child walks alone. Gut Health Empowers Development — ensuring robust microbiotas for all children with autism.
